Progenesis Technologies
Progenesis Technologies: Innovating in bacterial alginate research for industrial, medical, and defense applications since 2006.
Founded
2006Progenesis Technologies: Innovating in bacterial alginate research for industrial, medical, and defense applications since 2006.
Progenesis Technologies, LLC, founded in 2006, is dedicated to the research, development, and commercialization of genetically-engineered bacterial alginates. The company's core mission is to innovate and provide advanced solutions for industrial, medical, and defense applications. Their product offerings include absorbent bacterial alginate for moisture control in sanitary pads and agricultural/home gardening markets, as well as genetically engineered bacterial alginate for radioisotope decontamination, catering to military, homeland security, and civil defense needs.
Notable affiliated individuals and investors have not been disclosed publicly. Key achievements include the successful development of specialized bacterial alginates that address critical needs across diverse sectors. Progenesis Technologies has made a significant impact by providing cutting-edge biotechnological solutions that enhance safety and efficiency in both civilian and defense contexts.
Companies similar to Progenesis Technologies include EndGenitor Technologies, Conagen, Evogen and GenPrime.
Progenesis Technologies was founded in 2006.
Progenesis Technologies' headquarters is located in South Charleston, WV, US.
Progenesis Technologies' most recent funding round was for $100k (USD) in July 2010.
As of Jul 15, 2010, Progenesis Technologies has disclosed funding of $100k (USD). Undisclosed round amounts are excluded.
Progenesis Technologies has 30 employees as of Feb 5, 2024.
GenPrime
genprime.com
